Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1
Clinical medicine. Pathology · 2008
DOI: 10.4137/cpath.s1002 ↗At a glance
Journal article in Clinical medicine. Pathology, 2008. Written by Mauro Geller and 9 co-authors. Institution: Teresópolis Medical School (UNIFESO)-Teresópolis, Rio de Janeiro, Brazil. Cited 15 times so far (Crossref); 21 references. The full text is freely available in PubMed Central.
Abstract (original language)
Neurofibromatosis type 1 (NF1) or von Recklinghausen disease is a genetic disorder affecting the growth of cells in nervous system. One of the most remarkable characteristics of this disease is the development of benign tumors of the nervous system (neurofibromas). The purpose of this study was to test tissue samples taken from neurofibromas and plexiform neurofibromas of NF1 patients for the presence of estrogen and progesterone receptors. We used previously collected samples from patients registered in the database of the Centro Nacional de Neurofibromatose (CNNF-Brazil). Samples from twenty-five patients in the database presenting plexiform neurofibromas (N1 group) and 25 samples from the same database from patients presenting neurofibromas (N2 group) were tested. We observed positive staining for progesterone receptors in 13 of the neurofibroma samples and 19 of the plexiform neurofibroma samples. Among the neurofibroma samples, we observed one sample with positive estrogen receptor staining, but none of the plexiform neurofibroma samples showed positive staining. We suggest further studies to investigate in greater depth possible hormonal influences on the development and growth of neurofibromas and plexiform neurofibromas in NF1.
Subjects
Author keywords
Authors and institutions
- Teresópolis Medical School (UNIFESO)-Teresópolis, Rio de Janeiro, Brazil.
Cite
APA
Geller, M., Mezitis, S. G., Nunes, F. P., Ribeiro, M. G., Araújo, A. P., Bronstein, M. D., Siqueira-Batista, R., Gomes, A. P., Oliveira, L., & Cunha, K. S. (2008). Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1. Clinical medicine. Pathology. https://doi.org/10.4137/cpath.s1002
Vancouver
Geller M, Mezitis SG, Nunes FP, Ribeiro MG, Araújo AP, Bronstein MD, et al. Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1. Clinical medicine. Pathology. 2008. doi:10.4137/cpath.s1002
BibTeX
@article{Geller2008,
author = {Geller, Mauro and Mezitis, Spyros G E and Nunes, Fabio Pereira and Ribeiro, Marcia G and Araújo, Alexandra Prufer de Q C and Bronstein, Marcello D and Siqueira-Batista, Rodrigo and Gomes, Andréia Patrícia and Oliveira, Lisa and Cunha, Karin Soares Gonçalves},
title = {Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1},
journal = {Clinical medicine. Pathology},
year = {2008},
doi = {10.4137/cpath.s1002}
}
EUVIMED